A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: The neuropsychiatric inventory median cutoff is a predictor of clinical outcome

Journal of Clinical Psychiatry

Volumn 65, Issue 1, 2004, Pages 114-119

  Ballard, Clive G ^a   Thomas, Alan ^a   Fossey, Jane ^b   Lee, Lesley ^a   Jacoby, Robin ^b   Lana, Marisa M ^a   Bannister, Carol ^b   McShane, Rupert ^b   Swann, Alan ^a   Juszczak, Ed ^b   O'Brien, John T ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^b WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; PLACEBO;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; FEMALE; HUMAN; MALE; PATIENT; PREDICTION AND FORECASTING; PROGNOSIS; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; DEMENTIA; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; PATIENT DROPOUTS; PLACEBOS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; QUALITY OF LIFE; TREATMENT OUTCOME; WITHHOLDING TREATMENT;

EID: 1442357988     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v65n0120     Document Type: Article

References (31)

1. Magaziner J, German P, Zimmerman SI, et al, for the Epidemiology of Dementia in Nursing Homes Research Group. The prevalence of dementia in a statewide sample of new nursing home admissions aged 65 and older: diagnosis by expert panel. Gerontologist 2000;40:663-672
2. Furniss L, Craig SK, Burns A. Medication use in nursing homes for elderly. Int J Geriatr Psychiatry 1998;13:433-439 (Pubitemid 28370548)
3. McGrath AM, Jackson GA. Survey of prescribing in residents of nursing homes in Glasgow. BMJ 1996;312:611-612 (Pubitemid 26079597)
4. Ballard CG, O'Brien JT. Pharmacological treatment of behavioral and psychological signs in Alzheimer's disease: how good is the evidence for current pharmacological treatments? BMJ 1999;319:138-139
5. Ballard C, O'Brien J, Coope B, et al. A prospective study of psychotic symptoms in dementia sufferers: psychosis in dementia. Int Psychogeriatr 1997;9:57-64 (Pubitemid 27281606)
6. Ballard C, O'Brien J, Swann A, et al. A 1-year follow-up study of behavioral and psychological symptoms in dementia (BPSD) among people in care environments. J Clin Psychiatry 2001;62:631-636 (Pubitemid 32848168)
7. Tune LE, Steele C, Cooper T. Neuroleptic drugs in the management of behavioral symptoms of Alzheimer's disease. Psychiatr Clin North Am 1991;14:353-373
8. Reilly JG, Ayis SA, Ferrier IN, et al. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 2000;355:1048-1052 (Pubitemid 30162807)
9. McKeith IG, Fairbairn A, Perry R, et al. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ 1992;305:673-678
10. McShane R, Keene J, Gedling K, et al. Do neuroleptic drugs hasten cognitive decline in dementia? prospective study with necropsy follow-up. BMJ 1997;314:266-270 (Pubitemid 27047381)
11. Court JA, Piggott MA, Lloyd S, et al. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication. Neuroscience 2000;98:79-87
12. Chen CP, Alder JT, Bowen DM, et al. Presynaptic serotonergic markers in community-acquired cases of Alzheimer's disease: correlations with depression and neuroleptic medication. J Neurochem 1996;66;1592-1598 (Pubitemid 26090562)
13. Shorr R, Fought RL, Ray WA. Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations. J Am Med Assoc 1994;271:358-362 (Pubitemid 24037909)
14. Department of Health Public Health Link. CMO's Urgent Communication CEM/CMO/2000/18. Available at: http://www.doh.gov.uk/cmo/urgentarchive/cmo00-18. htm. Accessed Sept 2003
15. Margallo-Lana M, Swann A, O'Brien J, et al. Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments. Int J Geriatr Psychiatry 2001;16:39-44 (Pubitemid 32111815)
16. Gilley DW, Whalen ME, Wilson RS, et al. Hallucinations and associated factors in Alzheimer's disease. J Neuropsychiatry Clin Neurosci 1991;3:371-376
17. Ballard CG, Eastwood C, Gahir M, et al. A follow up study of depression in the carers of dementia sufferers. BMJ 1996;312:947 (Pubitemid 26111786)
18. Fitz D, Mallya A. Behavioral reactions to psychotropic medication changes for nursing home residents receiving psychogeriatric programming. J Appl Gerontol 1990;9:194-210 (Pubitemid 20203182)
19. Thapa PB, Meador KG, Gideon P, et al. Effects of antipsychotic withdrawal in elderly nursing home residents. J Am Geriatr Soc 1994;42:280-286 (Pubitemid 24079870)
20. Bridges-Parlet S, Knopman D, Steffes S. Withdrawal of neuroleptic medications from institutionalized dementia patients: results of a double-blind, baseline-treatment-controlled pilot study. J Geriatr Psychiatry Neurol 1997;10:119-126 (Pubitemid 27478613)
21. Cohen-Mansfield J, Lipson S, Werner P, et al. Withdrawal of haloperidol, thioridazine, and lorazepam in the nursing home: a controlled, double-blind study. Arch Intern Med 1999;159:1733-1740 (Pubitemid 29379136)
22. Ballard C, O'Brien J, James I, et al. Quality of life for people with dementia living in residential and nursing home care: the impact of dependency, behavioral and psychological symptoms, language skills and psychotropic drugs. Int Psychogeriatr 2001;13:93-106 (Pubitemid 32411153)
23. McKhann G. Drachman D. Folstein M. et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944 (Pubitemid 14076461)
24. Hughes CP, Berg L, Danziger WL, et al. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:556-572
25. Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-2314 (Pubitemid 24382728)
26. Folstein MF, Folstein SE, and McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198
27. Kitwood T, Bredin K, and the Bradford Dementia Research Group. Evaluating Dementia Care: The DCM Method. 7th ed. Bradford: Bradford University; 1997
28. Brooker D, Foster N, Banner A, et al. The efficacy of dementia care mapping as an audit tool: report of a 3-year British NHS evaluation. Aging Ment Health 1998;2:60-70 (Pubitemid 28118766)
29. Fossey J, Lee L, Ballard C. Dementia Care Mapping as a research tool for measuring quality of life in care settings: psychometric properties. Int J Geriatr Psychiatry 2002;17:1064-1070 (Pubitemid 35363425)
30. Kitwood T. Person and process in dementia. Int J Geriatr Psychiatry 1993;8:541-546
31. SPSS/PCT. Statistical Package for the Social Services. Chicago, Ill: SPSS; 1992